Fintel reports that on February 20, 2025, Piper Sandler upgraded their outlook for Clearwater Analytics Holdings (NYSE:CWAN) from Neutral to Overweight. As of February 19, 2025, the average one ...

Fintel reports that on February 19, 2025, Piper Sandler initiated coverage of Compass Therapeutics (NasdaqCM:CMPX) with a Overweight recommendation. As of January 29, 2025, the average one-year ...

Fintel reports that on February 18, 2025, Piper Sandler initiated coverage of enGene Holdings (NasdaqCM:ENGN) with a Overweight recommendation. As of January 28, 2025, the average one-year price ...

Fintel reports that on February 13, 2025, Piper Sandler initiated coverage of Merus N.V. (NasdaqGM:MRUS) with a Overweight recommendation. As of January 29, 2025, the average one-year price target ...

Insulet (NASDAQ:PODD – Get Free Report) had its price objective boosted by analysts at Piper Sandler from $285.00 to $310.00 ...

Trupanion (NASDAQ:TRUP – Free Report) had its target price trimmed by Piper Sandler from $57.00 to $52.00 in a research ...

Wix.com (NASDAQ:WIX – Get Free Report) had its price objective lifted by equities research analysts at Piper Sandler from ...

Piper Sandler Companies (PIPR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...

Piper Sandler Companies (PIPR) came out with quarterly earnings of $4.80 per share, beating the Zacks Consensus Estimate of $3.62 per share. This compares to earnings of $4.03 per share a year ago.

Fintel reports that on January 31, 2025, Piper Sandler downgraded their outlook for Hershey (WBAG:HSY) from Neutral to Underweight. There are 2,171 funds or institutions reporting positions in ...

Fintel reports that on February 7, 2025, Piper Sandler upgraded their outlook for Nevro (NYSE:NVRO) from Underweight to Neutral. As of January 28, 2025, the average one-year price target for Nevro ...

Piper Sandler Companies PIPR has announced a new share repurchase plan. The board of directors has approved the repurchase of up to $150 million worth of shares of PIPR’s outstanding stock.